๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Serum hyperglycosylated hCG: a potential screening test for fetal Down syndrome

โœ Scribed by Shohreh Shahabi; Utku A. Oz; Ray O. Bahado-Singh; Maurice J. Mahoney; Aziza Omrani; Alexander Baumgarten; Laurence A. Cole


Publisher
John Wiley and Sons
Year
1999
Tongue
English
Weight
111 KB
Volume
19
Category
Article
ISSN
0197-3851

No coin nor oath required. For personal study only.

โœฆ Synopsis


correctly normalize urine data. The tighter distribution of hyperglycosylated hCG measurements in serum may compensate for the lesser elevation of values in Down syndrome cases. Hyperglycosylated hCG determinations might be equally useful in urine and serum samples. 60 per cent sensitivity is suggested with as little as 1.5 per cent false-positive rate. It might be possible to combine serum hyperglycosylated hCG with established serum markers to achieve higher detection rates. Hyperglycosylated hCG measurements could, for instance, replace or supplement regular hCG in the serum triple-screen test. Larger studies are now needed to confirm these preliminary observations.


๐Ÿ“œ SIMILAR VOLUMES


Urinary screening tests for fetal Down s
โœ Laurence A. Cole; Shohreh Shahabi; Utku A. Oz; Kirsi M. Rinne; Aziza Omrani; Ray ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 212 KB ๐Ÿ‘ 2 views

Hyperglycosylated hCG is a form of hCG with more complex oligosaccharide side chains. A specific immunoassay was developed to measure hyperglycosylated hCG. Levels were measured in urine samples from 1157 women between 11 to 22 weeks of gestation, undergoing genetic analysis because of advanced mate

Hyperglycosylated hcg, a potential alter
โœ Laurence A. Cole; Aziza Omrani; Dilek Cermik; Ray O. Bahado Singh; Maurice J. Ma ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 179 KB ๐Ÿ‘ 1 views

Hyperglycosylated hCG (H-hCG) is a minor variant of hCG with abnormal oligosaccharide side chains. It is the principal gonadotropin detected in the serum and urine of patients with gestational choriocarcinoma. A monoclonal antibody was produced against this antigen and an immunoassay developed. Leve

MATERNAL SERUM SCREENING FOR FETAL DOWN
โœ L. S. M. RIBBERT; L. H. KORNMAN; B. T. H. M. DE WOLF; A. H. M. SIMONS; C. A. M. ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 322 KB ๐Ÿ‘ 2 views

To assess the influence of in vitro fertilization (IVF) on maternal serum human chorionic gonadotrophin (hCG) and alpha-fetoprotein (AFP), the maternal serum hCG and AFP values were studied in 67 IVF pregnancies and compared with the results of a control group of 4732 spontaneously conceiving patien

hCG and the free ฮฒ-subunit as screening
โœ George J. Knight; Glenn E. Palomaki; Louis M. Neveux; Karen K. Fodor; James E. H ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 99 KB ๐Ÿ‘ 1 views

Published studies have reached varying conclusions as to the benefit of replacing human chorionic gonadotropin (hCG) measurements with the free -subunit of hCG (the free -subunit) for Down syndrome screening. One study reports 14 per cent higher detection for the free -subunit, while another finds a

Urinary screening tests for fetal Down s
โœ Laurence A. Cole; Kirsi M. Rinne; Smita M. Mahajan; Utku A. Oz; Shohreh Shahabi; ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 248 KB ๐Ÿ‘ 1 views

Variable results have been reported using urine -core fragment as a marker for fetal Down syndrome. Initial studies by Cuckle et al. (1994) and Canick et al. (1995) indicated that -core fragment was an outstanding marker, detecting >80 per cent of Down syndrome cases. Since these reports, widely var